Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, June 27, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Amsellem Reiterated (AMPH) at Buy and Held Target at $71 on, Jun 27th, 2024
David Amsellem of Piper Sandler, Reiterated "Amphastar Pharmaceuticals, Inc." (AMPH) at Buy and Held Target at $71 on, Jun 27th, 2024.
David has made no other calls on AMPH in the last 4 months.
There are 2 other peers that have a rating on AMPH. Out of the 2 peers that are also analyzing AMPH, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Serge Belanger of "Needham" Reiterated at Hold on, Wednesday, May 22nd, 2024
This is the rating of the analyst that currently disagrees with David
- Ekaterina Knyazkova of "JP Morgan" Initiated at Buy and Held Target at $60 on, Tuesday, March 5th, 2024
